Skip to content
OpenCapital
Get started

SiriusPoint SPNT Cash, Cash Equivalents, Restricted Cash, Restricted Cash Equivalents And Restricted Investments

Other financials

Income statement

See full
Revenue$774.6M+6.5%
Net income$102.2M+65.9%
EPS (diluted)$0.82+67.3%

Balance sheet

See full
Cash & equivalents$1.0B+9.2%
Total debt$702.9M+2.2%
Total equity$2.3B+13.7%
Total assets$12.5B+1.6%

Cash flow

See full
Operating cash flow$141.9M+260%

Valuation

See full
Market cap$2.78B+25.6%
Enterprise value$2.47B+25.1%
P/E5.6×-6.5×
P/S0.9×0.0×

Profitability

See full
Net margin15.4%+8.4pp

Returns & leverage

See full
Return on equity23.1%+15.2pp
Debt / equity0.3×0.0×

Where this comes from

Reported directly by SiriusPoint in its filing.

Tagged under the XBRL concept spnt:CashCashEquivalentsRestrictedCashRestrictedCashEquivalentsAndRestrictedInvestments.

The official record: SiriusPoint’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about SiriusPoint's cash, cash equivalents, restricted cash, restricted cash equivalents and restricted investments.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is SiriusPoint's cash, cash equivalents, restricted cash, restricted cash equivalents and restricted investments?
SiriusPoint (SPNT) reported cash, cash equivalents, restricted cash, restricted cash equivalents and restricted investments of $2.85B in Q1 2026.
How has SiriusPoint's cash, cash equivalents, restricted cash, restricted cash equivalents and restricted investments changed year-over-year?
SiriusPoint's cash, cash equivalents, restricted cash, restricted cash equivalents and restricted investments decreased by 9.2% year-over-year, from $3.14B to $2.85B.
What is the long-term trend for SiriusPoint's cash, cash equivalents, restricted cash, restricted cash equivalents and restricted investments?
Over 5 years (2020 to 2025), SiriusPoint's cash, cash equivalents, restricted cash, restricted cash equivalents and restricted investments has grown at a 10.3% compound annual growth rate (CAGR), from $1.8B to $2.94B.